This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WebMD Study: U.S. Doctors Deeply Divided On Many Matters Of Ethical Ambiguity

NEW YORK, Nov. 19, 2012 /PRNewswire/ -- WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, today released the findings of a new survey from Medscape from WebMD that reveals U.S. physicians are deeply divided on many ethical decisions that could significantly impact patients and their families.

Medscape's 2012 Ethics Survey examined how more than 24,000 U.S. physicians would react when faced with a wide range of ethical dilemmas, including end-of-life care, physician performance, abortion, romantic relationships with patients, malpractice, insurance, and patient communications and consent.

"The increasing number of conflicting forces makes ethical decisions tougher and more wrenching for physicians," said Leslie Kane, MA, executive editor of Medscape Business of Medicine. "Technological advances, new regulations, and more pressure to control costs all fight with the doctors' desire to give patients the best possible care. Some ethical issues are life-and-death struggles, and doctors take them strongly to heart."

With continuing technological advancements, compounded with mandates for the appropriate expenditure of resources, physicians are facing more ethical issues than in the past.
  • Defensive Medicine: When asked if it is acceptable to perform "unnecessary" procedures because of malpractice concerns, 23% of physicians responded "yes," 55% "no," and 22% said "it depends."
  • Cost Containment: When asked if a patient who is "nonadherent" or "overuses" resources should be dismissed, 32% responded "yes," 33% said "no," and 36% said "it depends."
  • Insurance: When asked if insurers should be dropped if they do not pay well, even if longtime patients must stop seeing them, 27% of physicians surveyed responded "yes," 41% said "no," and 33% said "it depends."

Decisions about the legal and financial implications of recommended care were not the only contentious issues among physicians. End-of-life care, which has been a key ethical dilemma during recent years, also revealed a sharp divide among physicians:
  • When asked if physician-assisted suicide should be allowed in some situations, 47% of physicians said "yes," 40% said "no," and 13% said "it depends."
  • When asked if they would give life-sustaining therapy if they believe it to be futile, 35% said "yes," 24% said "no," and 41% said "it depends."

"Armed with technology that can keep many terminally ill patients alive for months and years, doctors today face an extremely complicated decision that is often compounded by the wishes of family members," Kane said. "Despite the complexity of these dilemmas, our survey revealed that doctors feel a significant amount of compassion for their patients -- even if that might lead them to consider actions that may risk their medical license."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs